Publications for Matthew Kiernan
Publications for Matthew Kiernan
2016
Kiernan, M. (2016). 35,000 Days on Earth.
Journal of Neurology, Neurosurgery and
Psychiatry, 87(1), 1-2. <a
href="http://dx.doi.org/10.1136/jnnp-2015-31268
6">[More Information]</a>
Garg, N., Yuki, N., Park, S., Barnett, M.,
Kiernan, M. (2016). Acute bulbar, neck and limb
weakness with monospecific anti-GT1a
antibody: A rare localized subtype of
Guillain-Barre sydnrome. Muscle and Nerve,
53(1), 143-146. <a
href="http://dx.doi.org/10.1002/mus.24935">[M
ore Information]</a>
Murray, L., Butow, P., White, K., Kiernan, M.,
D'Abrew, N., Herz, H. (2016). Advance care
planning in motor neuron disease: A qualitative
study of caregiver perspectives. Palliative
Medicine, 30(5), 471-478. <a
href="http://dx.doi.org/10.1177/0269216315613
902">[More Information]</a>
Caga, J., Turner, M., Hsieh, S., ahmed, R.,
Devenney, E., Ramsey, E., Zoing, M., Mioshi,
E., Kiernan, M. (2016). Apathy is associated
with poor prognosis in amyotrophic lateral
sclerosis. European Journal of Neurology, 23(5),
891-897. <a
href="http://dx.doi.org/10.1111/ene.12959">[Mo
re Information]</a>
Ahmed, R., Irish, M., Henning, E., Dermody, N.,
Bartley, L., Kiernan, M., Piguet, O., Farooqi, S.,
Hodges, J. (2016). Assessment of Eating
Behavior Disturbance and Associated Neural
Networks in Frontotemporal Dementia. JAMA
Neurology, 73(3), 282-290. <a
href="http://dx.doi.org/10.1001/jamaneurol.2015
.4478">[More Information]</a>
Huynh, W., Simon, N., Großkreutz, J., Turner,
M., Vucic, S., Kiernan, M. (2016). Assessment
of the upper motor neuron in amyotrophic lateral
sclerosis. Clinical Neurophysiology, 127(7),
2643-2660. <a
href="http://dx.doi.org/10.1016/j.clinph.2016.04.
025">[More Information]</a>
Barnett, M., Mathey, E., Kiernan, M., Pollard, J.
(2016). Axon damage in central nervous system
and peripheral nervous system inflammatory
demyelinating diseases: common and divergent
pathways of dysfunction and tissue damage.
Current Opinion In Neurology, 29(3), 213-221.
<a
href="http://dx.doi.org/10.1097/WCO.00000000
00000334">[More Information]</a>
Tan, R., Kril, J., McGinley, C., Hassani, M.,
Masuda-Suzukake, M., Hasegawa, M., Mito, R.,
Kiernan, M., Halliday, G. (2016). Cerebellar
neuronal loss in Amyotrophic Lateral Sclerosis
cases with ATXN2 intermediate repeat
expansions. Annals of Neurology, 79(2),
295-305. <a
href="http://dx.doi.org/10.1002/ana.24565">[Mo
re Information]</a>
Hsieh, S., Caga, J., Leslie, F., Shibata, M.,
Daveson, N., Foxe, D., Ramsey, E., Lillo, P.,
Ahmed, R., Devenney, E., Kiernan, M., et al
(2016). Cognitive and Behavioral Symptoms in
ALSFTD: Detection, Differentiation, and
Progression. Journal of Geriatric Psychiatry and
Neurology, 29(1), 3-10. <a
href="http://dx.doi.org/10.1177/0891988715598
232">[More Information]</a>
Simon, N., Kiernan, M. (2016). Diaphragm
ultrasound in amyotrophic lateral sclerosis and
other neuromuscular disorders. Clinical
Neurophysiology, 127(1), 28-30. <a
href="http://dx.doi.org/10.1016/j.clinph.2015.04.
066">[More Information]</a>
Bae, J., Ferguson, M., Tan, R., Mioshi, E.,
Simon, N., Burrell, J., Vucic, S., Hodges, J.,
Kiernan, M., Hornberger, M. (2016).
Dissociation of structural and functional
integrities of the motor system in amyotrophic
lateral sclerosis and behavioral-variant
frontotemporal dementia. Journal of Clinical
Neurology, 12(2), 209-217. <a
href="http://dx.doi.org/10.3988/jcn.2016.12.2.20
9">[More Information]</a>
Huynh, W., Pickering, H., Howells, J., Murray,
J., Cormack, C., Lin, C., Vucic, S., Kiernan, M.,
Krishnan, A. (2016). Effect of fampridine on
axonal excitability in multiple sclerosis. Clinical
Neurophysiology, 127(7), 2636-2642. <a
href="http://dx.doi.org/10.1016/j.clinph.2016.04.
010">[More Information]</a>
Hornberger, M., Kiernan, M. (2016). Emergence
of an imaging biomarker for amyotrophic lateral
sclerosis: is the end point near? Journal of
Neurology, Neurosurgery and Psychiatry, 87(6),
569-569. <a
href="http://dx.doi.org/10.1136/jnnp-2015-31288
2">[More Information]</a>
Huynh, W., Vucic, S., Krishnan, A., Lin, C.,
Kiernan, M. (2016). Exploring the evolution of
cortical excitability following acute stroke.
Neurorehabilitation and Neural Repair, 30(3),
244-257. <a
href="http://dx.doi.org/10.1177/1545968315593
804">[More Information]</a>
Kwai, N., Arnold, R., Poynten, A., Howells, J.,
Kiernan, M., Lin, C., Krishnan, A. (2016). In
vivo evidence of reduced nodal and paranodal
conductances in type 1 diabetes. Clinical
Neurophysiology, 127(2), 1700-1706. <a
href="http://dx.doi.org/10.1016/j.clinph.2015.11.
Publications for Matthew Kiernan
047">[More Information]</a>
De Silva, D., Hsieh, S., Caga, J., Leslie, F.,
Kiernan, M., Hodges, J., Mioshi, E., Burrell, J.
(2016). Motor function and behaviour across the
ALS-FTD spectrum. Acta Neurologica
Scandinavica, 133(5), 367-372. <a
href="http://dx.doi.org/10.1111/ane.12471">[Mo
re Information]</a>
Menezes, M., Farrar, M., Webster, R., Antony,
J., O'Brien, K., Ouvrier, R., Kiernan, M., Burns,
J., Vucic, S. (2016). Pathophysiology of motor
dysfunction in a childhood motor neuron disease
caused by mutations in the riboflavin transporter.
Clinical Neurophysiology, 127(1), 911-918. <a
href="http://dx.doi.org/10.1016/j.clinph.2015.05.
012">[More Information]</a>
Simon, N., Lagopoulos, J., Gallagher, T., Kliot,
M., Kiernan, M. (2016). Peripheral nerve
diffusion tensor imaging is reliable and
reproducible. Journal of Magnetic Resonance
Imaging, 43(4), 962-969. <a
href="http://dx.doi.org/10.1002/jmri.25056">[M
ore Information]</a>
Grieve, S., Menon, P., Korgaonkar, M., Gomes,
L., Foster, S., Kiernan, M., Vucic, S. (2016).
Potential structural and functional biomarkers of
upper motor neuron dysfunction in ALS.
Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 17, 85-92. <a
href="http://dx.doi.org/10.3109/21678421.2015.
1074707">[More Information]</a>
Ahmed, R., Newcombe, R., Piper, A., Lewis, S.,
A/Prof Yee, B., Kiernan, M., Grunstein, R.
(2016). Sleep disorders and respiratory function
in amyotrophic lateral sclerosis. Sleep Medicine
Reviews, 26, 33-42. <a
href="http://dx.doi.org/10.1016/j.smrv.2015.05.0
07">[More Information]</a>
Devine, M., Ballard, E., O'Rourke, P., Kiernan,
M., McCombe, P., Henderson, R. (2016).
Targeted assessment of lower motor neuron
burden is associated with survival in
amyotrophic lateral sclerosis. Amyotrophic
Lateral Sclerosis and Frontotemporal
Degeneration, 17(3-4), 184-190. <a
href="http://dx.doi.org/10.3109/21678421.2015.
1125502">[More Information]</a>
Halliday, G., Kiernan, M., Kril, J., Mito, R.,
Masuda-Suzukake, M., Hasegawa, M., McCann,
H., Bartley, L., Dobson-Stone, C., Kwok, J., et al
(2016). TDP-43 in the hypoglossal nucleus
identifies amyotrophic lateral sclerosis in
behavioral variant frontotemporal dementia.
Journal of the Neurological Sciences, 366,
197-201. <a
href="http://dx.doi.org/10.1016/j.jns.2016.05.005
">[More Information]</a>
Hsieh, S., Leyton, C., Caga, J., Flanagan, E.,
Kaizik, C., O'Connor, C., Kiernan, M., Hodges,
J., Piguet, O., Mioshi, E. (2016). The Evolution
of Caregiver Burden in Frontotemporal
Dementia with and without Amyotrophic Lateral
Sclerosis. Journal of Alzheimer's Disease, 49(3),
875-885. <a
href="http://dx.doi.org/10.3233/JAD-150475">[
More Information]</a>
Shibuya, K., Park, S., Geevasinga, N., Huynh,
W., Simon, N., Menon, P., Howells, J., Vucic, S.,
Kiernan, M. (2016). Threshold tracking
transcranial magnetic stimulation: Effects of age
and gender on motor cortical function. Clinical
Neurophysiology, 127(6), 2355-2361. <a
href="http://dx.doi.org/10.1016/j.clinph.2016.03.
009">[More Information]</a>
2015
Kiernan, M. (2015). A fine neuroscience vintage.
Journal of Neurology, Neurosurgery, and
Psychiatry, 86(1), 1-2. <a
href="http://dx.doi.org/10.1136/jnnp-2014-30989
9">[More Information]</a>
Caga, J., Ramsey, E., Hogden, A., Mioshi, E.,
Kiernan, M. (2015). A longer diagnostic interval
is a risk for depression in amyotrophic lateral
sclerosis. Palliative and Supportive Care, 13(4),
1019-1024. <a
href="http://dx.doi.org/10.1017/S147895151400
0881">[More Information]</a>
Huynh, W., Kiernan, M. (2015). A unique
account of ALS in China: exploring ethnic
heterogeneity. Journal of Neurology,
Neurosurgery, and Psychiatry, 86(10),
1051-1052. <a
href="http://dx.doi.org/10.1136/jnnp-2015-31047
1">[More Information]</a>
Ahmed, R., Iodice, V., Daveson, N., Kiernan,
M., Piguet, O., Hodges, J. (2015). Autonomic
dysregulation in frontotemporal dementia.
Journal of Neurology, Neurosurgery, and
Psychiatry, 86(9), 1048-1049. <a
href="http://dx.doi.org/10.1136/jnnp-2014-30942
4">[More Information]</a>
Wang, C., Paling, D., Chen, L., Hatton, S.,
Lagopoulos, J., Aw, S., Kiernan, M., Barnett, M.
(2015). Axonal conduction in multiple sclerosis:
A combined magnetic resonance imaging and
electrophysiological study of the medial
longitudinal fasciculus. Multiple Sclerosis
Journal, 21(7), 905-915. <a
href="http://dx.doi.org/10.1177/1352458514556
301">[More Information]</a>
Geevasinga, N., Menon, P., Howells, J.,
Nicholson, G., Kiernan, M., Vucic, S. (2015).
Axonal Ion Channel Dysfunction in C9orf72
Familial Amyotrophic Lateral Sclerosis. JAMA
Publications for Matthew Kiernan
Neurology, 72(1), 49-57. <a
href="http://dx.doi.org/10.1001/jamaneurol.2014
.2940">[More Information]</a>
Ahmed, R., Kaizik, C., Irish, M., Mioshi, E.,
Dermody, N., Kiernan, M., Piguet, O., Hodges, J.
(2015). Characterizing sexual behavior in
frontotemporal dementia. Journal of Alzheimer's
Disease, 46(3), 677-686. <a
href="http://dx.doi.org/10.3233/JAD-150034">[
More Information]</a>
Mathey, E., Park, S., Hughes, R., Pollard, J.,
Armati, P., Barnett, M., Taylor, B., Dyck, J.,
Kiernan, M., Lin, C. (2015). Chronic
inflammatory demyelinating
polyradiculoneuropathy: from pathology to
phenotype. Journal of Neurology, Neurosurgery
and Psychiatry, 86(9), 973-985. <a
href="http://dx.doi.org/10.1136/jnnp-2014-30969
7">[More Information]</a>
Devenney, E., Foxe, D., Dobson-Stone, C.,
Kwok, J., Kiernan, M., Hodges, J. (2015).
Clinical heterogeneity of the C9orf72 genetic
mutation in frontotemporal dementia. Neurocase,
21(4), 535-541. <a
href="http://dx.doi.org/10.1080/13554794.2014.
951058">[More Information]</a>
Kwai, N., Arnold, R., Poynten, A., Lin, C.,
Kiernan, M., Krishnan, A. (2015). Continuous
subcutaneous insulin infusion preserves axonal
function in Type 1 diabetes mellitus.
Diabetes/Metabolism Research and Reviews,
31(2), 175-182. <a
href="http://dx.doi.org/10.1002/dmrr.2583">[Mo
re Information]</a>
Geevasinga, N., Menon, P., Sue, C., Kumar, K.,
Ng, K., Yiannikas, C., Kiernan, M., Vucic, S.
(2015). Cortical excitability changes distinguish
the motor neuron disease phenotypes from
hereditary spastic paraplegia. European Journal
of Neurology, 22(5), 826-831. <a
href="http://dx.doi.org/10.1111/ene.12669">[Mo
re Information]</a>
Geevasinga, N., Menon, P., Nicholson, G., Ng,
K., Howells, J., Kril, J., Yannikas, C., Kiernan,
M., Vucic, S. (2015). Cortical Function in
Asymptomatic Carriers and Patients With
C9orf72 Amyotrophic Lateral Sclerosis. JAMA
Neurology, 72(11), 1268-1274. <a
href="http://dx.doi.org/10.1001/jamaneurol.2015
.1872">[More Information]</a>
Menon, P., Kiernan, M., Vucic, S. (2015).
Cortical hyperexcitability precedes lower motor
neuron dysfunction in ALS. Clinical
Neurophysiology, 126(4), 803-809. <a
href="http://dx.doi.org/10.1016/j.clinph.2014.04.
023">[More Information]</a>
Hogden, A., Greenfield, D., Nugus, P., Kiernan,
M. (2015). Development of a model to guide
decision making in amyotrophic lateral sclerosis
multidisciplinary care. Health Expectations,
18(5), 1769-1782. <a
href="http://dx.doi.org/10.1111/hex.12169">[Mo
re Information]</a>
Simon, N., Lee, M., Bae, J., Mioshi, E., Lin, C.,
Pfluger, C., Henderson, R., Vucic, S., Swash, M.,
Burke, D., Kiernan, M. (2015). Dissociated
lower limb muscle involvement in amyotrophic
lateral sclerosis. Journal of Neurology, 262(6),
1424-1432. <a
href="http://dx.doi.org/10.1007/s00415-015-772
1-8">[More Information]</a>
Eisen, A., Lemon, R., Kiernan, M., Hornberger,
M., Turner, M. (2015). Does dysfunction of the
mirror neuron system contribute to symptoms in
amyotrophic lateral sclerosis? Clinical
Neurophysiology, 126, 1288-1294. <a
href="http://dx.doi.org/10.1016/j.clinph.2015.02.
003">[More Information]</a>
Ahmed, R., Latheef, S., Bartley, L., Irish, M.,
Halliday, G., Kiernan, M., Hodges, J., Piguet, O.
(2015). Eating behavior in frontotemporal
dementia. Neurology, 85(15), 1310-1317. <a
href="http://dx.doi.org/10.1212/WNL.00000000
00002018">[More Information]</a>
Lee, M., Meng, D., Kiernan, M., Johnson, B.
(2015). Exploring motor imagery and motor
cortical function in ALS using
magnetoencephalography. 16th Biennial Clinical
Neurophysiology Workshop of the Australian
and New Zealand Association of Neurologists,
Australia.
Lee, M., Meng, D., Kiernan, M., Johnson, B.
(2015). Exploring motor imagery and motor
cortical function in ALS using
magnetoencephalography. Asia Pacific FTD &
MND Meeting, Australia.
Lee, M., Meng, D., Kiernan, M., Johnson, B.
(2015). Exploring motor imagery and motor
cortical function in ALS using MEG. 26th
International Symposium on ALS/MND, Orlando
USA.
Park, S., Vucic, S., Cheah, B., Lin, C., Kirby, A.,
Mann, K., Zoing, M., Winhammar, J., Kiernan,
M. (2015). Flecainide in Amyotrophic Lateral
Sclerosis as a Neuroprotective Strategy (FANS):
A Randomized Placebo-Controlled Trial.
EBioMedicine, 2(12), 1916-1922. <a
href="http://dx.doi.org/10.1016/j.ebiom.2015.11.
022">[More Information]</a>
Ittner, L., Halliday, G., Kril, J., Gotz, J., Kiernan,
M. (2015). FTD and ALS-translating mouse
studies into clinical trials. Nature Reviews.
Neurology, 11(6), 360-366. <a
href="http://dx.doi.org/10.1038/nrneurol.2015.65
Publications for Matthew Kiernan
">[More Information]</a>
2-2">[More Information]</a>
Arnold, R., Huynh, W., Kiernan, M., Krishnan,
A. (2015). Ion Channel Modulation as a
Therapeutic Approach in Multiple Sclerosis.
Current Medicinal Chemistry, 22(38),
4366-4378.
Simon, N., Kiernan, M. (2015). Precise
correlation between structural and
electrophysiological disturbances in MADSAM
neuropathy. Neuromuscular Disorders, 25(11),
904-907. <a
href="http://dx.doi.org/10.1016/j.nmd.2015.07.0
12">[More Information]</a>
Lu, R., Kiernan, M., Murray, A., Rosner, M.,
Ronco, C. (2015). Kidney-brain crosstalk in the
acute and chronic setting. Nature Reviews
Nephrology, 11(12), 707-719. <a
href="http://dx.doi.org/10.1038/nrneph.2015.131
">[More Information]</a>
Kiernan, M., Turner, M. (2015). Lou Gehrig and
the ALS split hand. Neurology, 85(22),
1995-1995. <a
href="http://dx.doi.org/10.1212/WNL.00000000
00002172">[More Information]</a>
Swash, M., Kiernan, M. (2015). Measuring
change in amyotrophic lateral sclerosis. Journal
of Neurology, Neurosurgery and Psychiatry,
86(11), 1169-1170. <a
href="http://dx.doi.org/10.1136/jnnp-2015-31105
1">[More Information]</a>
Devenney, E., Vucic, S., Hodges, J., Kiernan, M.
(2015). Motor neuron disease-frontotemporal
dementia: A clinical continuum. Expert Review
of Neurotherapeutics, 15(5), 509-522. <a
href="http://dx.doi.org/10.1586/14737175.2015.
1034108">[More Information]</a>
Simon, N., Huynh, W., Vucic, S., Talbot, K.,
Kiernan, M. (2015). Motor neuron disease:
Current management and future prospects.
Internal Medicine Journal, 45(10), 1005-1013.
<a
href="http://dx.doi.org/10.1111/imj.12874">[Mo
re Information]</a>
Lee, M., Kiernan, M., Macefield, V., Lee, B.,
Lin, C. (2015). Nerve excitability changes in SCI
patients after high-frequency repetitive
peripheral nerve stimulation. International
Taiwanese Congress of Neurology, Taiwan.
Huynh, W., Lee, M., Kiernan, M. (2015).
Neurorehabilitation approaches for disorders of
the peripheral nervous system. In Volker Dietz,
Nick Ward (Eds.), The Oxford Textbook of
Neurorehabilitation, (pp. 224-237). Oxford:
Oxford University Press.
Kiernan, M. (2015). Palliative care in
amyotrophic lateral sclerosis. The Lancet
Neurology, 14(4), 347-348. <a
href="http://dx.doi.org/10.1016/S1474-4422(14)
70289-3">[More Information]</a>
Huynh, W., Kiernan, M. (2015). Peripheral nerve
axonal excitability studies: expanding the
neurophysiologist's armamentarium. Cerebellum
and Ataxias, 2, 1-5. <a
href="http://dx.doi.org/10.1186/s40673-015-002
Devenney, E., Bartley, L., Hoon, C.,
O'Callaghan, C., Kumfor, F., Hornberger, M.,
Kwok, J., Halliday, G., Kiernan, M., Piguet, O.,
et al (2015). Progression in Behavioral Variant
Frontotemporal Dementia: A Longitudinal
Study. JAMA Neurology, 72(12), 1501-1509. <a
href="http://dx.doi.org/10.1001/jamaneurol.2015
.2061">[More Information]</a>
Carswell, C., Northey, L., Davies, L., Yuki, N.,
Kiernan, M. (2015). Progressive bilateral facial
weakness. Practical Neurology, 15(1), 76-79. <a
href="http://dx.doi.org/10.1136/practneurol-2014
-000989">[More Information]</a>
Simon, N., Ralph, J., Lomen-Hoerth, C.,
Poncelet, A., Vucic, S., Kiernan, M., Kliot, M.
(2015). Quantitative ultrasound of denervated
hand muscles. Muscle and Nerve, 52(2),
221-230. <a
href="http://dx.doi.org/10.1002/mus.24519">[M
ore Information]</a>
Park, S., Sung, J., Tani, J., Kiernan, M., Lin, C.
(2015). Reply: biomarkers of 'acute-onset'
chronic inflammatory demyelinating
polyneuropathy. Brain, 138, 1-2. <a
href="http://dx.doi.org/10.1093/brain/awu254">[
More Information]</a>
Simon, N., Lin, C., Lee, M., Howells, J., Vucic,
S., Burke, D., Kiernan, M. (2015). Segmental
motoneuronal dysfunction is a feature of
amyotrophic lateral sclerosis. Clinical
Neurophysiology, 126(4), 828-836. <a
href="http://dx.doi.org/10.1016/j.clinph.2014.07.
029">[More Information]</a>
Leslie, F., Hsieh, S., Caga, J., Savage, S.,
Mioshi, E., Hornberger, M., Kiernan, M.,
Hodges, J., Burrell, J. (2015). Semantic deficits
in amyotrophic lateral sclerosis. Amyotrophic
Lateral Sclerosis and Frontotemporal
Degeneration, 16(1-2), 46-53. <a
href="http://dx.doi.org/10.3109/21678421.2014.
987301">[More Information]</a>
Menon, P., Geevasinga, N., Yiannikas, K.,
Howells, J., Kiernan, M., Vucic, S. (2015).
Sensitivity and specificity of threshold tracking
transcranial magnetic stimulation for diagnosis
of amyotrophic lateral sclerosis: A prospective
study. The Lancet Neurology, 14(5), 478-484. <a
href="http://dx.doi.org/10.1016/S1474-4422(15)
00014-9">[More Information]</a>
Publications for Matthew Kiernan
Lee, M., Kiernan, M., Macefield, V., Lee, B.,
Lin, C. (2015). Short-term peripheral nerve
stimulation ameliorates axonal dysfunction after
spinal cord injury. Journal of Neurophysiology,
113, 3209-3218. <a
href="http://dx.doi.org/10.1152/jn.00839.2014">
[More Information]</a>
Ke, Y., Hummel, A., Stevens, C., Gladbach, A.,
Ippati, S., Bi, M., Lee, W., Kruger, S., Hoven, J.,
Volkerling, A., Haass, N., Kiernan, M., et al
(2015). Short‑term suppression of A315T mutant
human TDP‑43 expression improves functional
deficits in a novel inducible transgenic mouse
model of FTLD‑TDP and ALS. Acta
Neuropathologica, 130(5), 661-678. <a
href="http://dx.doi.org/10.1007/s00401-015-148
6-0">[More Information]</a>
Tan, R., Kril, J., Fatima, M., McGeachie, A.,
McCann, H., Shepherd, C., Forrest, S., Affleck,
A., Kwok, J., Hodges, J., Kiernan, M., et al
(2015). TDP-43 proteinopathies: pathological
identification of brain regions differentiating
clinical phenotypes. Brain, 138(10), 3110-3122.
<a
href="http://dx.doi.org/10.1093/brain/awv220">[
More Information]</a>
Tan, R., Devenney, E., Kiernan, M., Halliday,
G., Hodges, J., Hornberger, M. (2015). Terra
incognita-cerebellar contributions to
neuropsychiatric and cognitive dysfunction in
behavioral variant frontotemporal dementia.
Frontiers in Aging Neuroscience, 7, 1-9. <a
href="http://dx.doi.org/10.3389/fnagi.2015.0012
1">[More Information]</a>
Farrar, M., Kiernan, M. (2015). The Genetics of
Spinal Muscular Atrophy: Progress and
Challenges. Neurotherapeutics, 12(2), 290-302.
<a
href="http://dx.doi.org/10.1007/s13311-014-031
4-x">[More Information]</a>
Turner, M., Kiernan, M. (2015). The standard of
care in amyotrophic lateral sclerosis: a
centralised multidisciplinary clinic encounter sets
a new benchmark for a uniquely challenging
neurodegenerative disorder. Journal of
Neurology, Neurosurgery, and Psychiatry, 86(5),
481-482. <a
href="http://dx.doi.org/10.1136/jnnp-2014-30982
9">[More Information]</a>
2014
Mioshi, E., Hsieh, S., Caga, J., Ramsey, E.,
Chen, K., Lillo, P., Simon, N., Vucic, S.,
Hornberger, M., Hodges, J., Kiernan, M. (2014).
A novel tool to detect behavioural symptoms in
ALS. Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 15(3-4), 298-304.
<a
href="http://dx.doi.org/10.3109/21678421.2014.
896927">[More Information]</a>
Ambikairajah, A., Devenney, E., Flanagan, E.,
Yew, B., Mioshi, E., Kiernan, M., Hodges, J.,
Hornberger, M. (2014). A visual MRI atrophy
rating scale for the amyotrophic lateral
sclerosis-frontotemporal dementia continuum.
Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 15(3-4), 226-234.
<a
href="http://dx.doi.org/10.3109/21678421.2014.
880180">[More Information]</a>
Vucic, S., Rothstein, J., Kiernan, M. (2014).
Advances in treating amyotrophic lateral
sclerosis: insights from pathophysiological
studies. Trends in Neurosciences, 37(8),
433-442. <a
href="http://dx.doi.org/10.1016/j.tins.2014.05.00
6">[More Information]</a>
Kiernan, M. (2014). ALS and neuromuscular
disease: In search of the Holy Grail. The Lancet
Neurology, 13(1), 13-14. <a
href="http://dx.doi.org/10.1016/S1474-4422(13)
70226-6">[More Information]</a>
Menon, P., Kiernan, M., Vucic, S. (2014). ALS
pathophysiology: Insights from the split-hand
phenomenon. Clinical Neurophysiology, 125(1),
186-193. <a
href="http://dx.doi.org/10.1016/j.clinph.2013.07.
022">[More Information]</a>
Eisen, A., Kiernan, M., Mitsumoto, H., Swash,
M. (2014). Amyotrophic lateral sclerosis: a long
preclinical period? Journal of Neurology,
Neurosurgery, and Psychiatry, 85(11),
1232-1238. <a
href="http://dx.doi.org/10.1136/jnnp-2013-30713
5">[More Information]</a>
Burrell, J., Hornberger, M., Vucic, S., Kiernan,
M., Hodges, J. (2014). Apraxia and Motor
Dysfunction in Corticobasal Syndrome. PloS
One, 9(3), e92944. <a
href="http://dx.doi.org/10.1371/journal.pone.009
2944">[More Information]</a>
Park, S., Lin, C., Krishnan, A., Simon, N.,
Bostock, H., Vincent, A., Kiernan, M. (2014).
Axonal dysfunction with voltage gated
potassium channel complex antibodies.
Experimental Neurology, 261, 337-342. <a
href="http://dx.doi.org/10.1016/j.expneurol.2014
.06.002">[More Information]</a>
Farrar, M., Park, S., Krishnan, A., Kiernan, M.,
Lin, C. (2014). Axonal dysfunction,
dysmyelination, and conduction failure in
hereditary neuropathy with liability to pressure
palsies. Muscle and Nerve, 49(6), 858-865. <a
href="http://dx.doi.org/10.1002/mus.24085">[M
ore Information]</a>
Menon, P., Kiernan, M., Vucic, S. (2014).
Publications for Matthew Kiernan
Biomarkers And Future Targets For
Development In Amyotrophic Lateral Sclerosis.
Current Medicinal Chemistry, 21(31),
3535-3550.
lateral sclerosis. European Journal of Neurology,
21(12), 1451-1457. <a
href="http://dx.doi.org/10.1111/ene.12422">[Mo
re Information]</a>
Ahmed, R., Mioshi, E., Caga, J., Shibata, M.,
Zoing, M., Bartley, L., Piguet, O., Hodges, J.,
Kiernan, M. (2014). Body mass index delineates
ALS from FTD: implications for metabolic
health. Journal of Neurology, 261(9), 1774-1780.
<a
href="http://dx.doi.org/10.1007/s00415-014-741
6-6">[More Information]</a>
Sung, J., Tani, J., Park, S., Kiernan, M., Lin, C.
(2014). Early identification of 'acute-onset'
chronic inflammatory demyelinating
polyneuropathy. Brain, 137(8), 2155-2163. <a
href="http://dx.doi.org/10.1093/brain/awu158">[
More Information]</a>
Tan, R., Devenney, E., Dobson-Stone, C., Kwok,
J., Hodges, J., Kiernan, M., Halliday, G.,
Hornberger, M. (2014). Cerebellar Integrity in
the Amyotrophic Lateral Sclerosis Frontotemporal Dementia Continuum. PloS One,
9(8), e105632. <a
href="http://dx.doi.org/10.1371/journal.pone.010
5632">[More Information]</a>
Simon, N., Vucic, S., Joffe, R., Kiernan, M.
(2014). Cortical dysfunction in cerebellar ataxia
with antibodies to glutamic acid decarboxylase.
Journal of Neurology, 261(1), 238-239. <a
href="http://dx.doi.org/10.1007/s00415-013-719
7-3">[More Information]</a>
Menon, P., Kiernan, M., Vucic, S. (2014).
Cortical dysfunction underlies the development
of the split-hand in amyotrophic lateral sclerosis.
PloS One, 9(1), 1-9. <a
href="http://dx.doi.org/10.1371/journal.pone.008
7124">[More Information]</a>
Menon, P., Kiernan, M., Vucic, S. (2014).
Cortical excitability differences in hand muscles
follow a split-hand pattern in healthy controls.
Muscle and Nerve, 49(6), 836-844. <a
href="http://dx.doi.org/10.1002/mus.24072">[M
ore Information]</a>
Bae, J., Menon, P., Mioshi, E., Kiernan, M.,
Vucic, S. (2014). Cortical hyperexcitability and
the split-hand plus phenomenon:
Pathophysiological insights in ALS.
Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 15(3-4), 250-256.
<a
href="http://dx.doi.org/10.3109/21678421.2013.
872150">[More Information]</a>
Savage, S., Lillo, P., Kumfor, F., Kiernan, M.,
Piguet, O., Hodges, J. (2014). Emotion
processing deficits distinguish pure amyotrophic
lateral sclerosis from frontotemporal dementia.
Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 15(1-2), 39-46.
<a
href="http://dx.doi.org/10.3109/21678421.2013.
809763">[More Information]</a>
Arnold, R., Pussell, B., Howells, J., Grinius, V.,
Kiernan, M., Lin, C., Krishnan, A. (2014).
Evidence for a causal relationship between
hyperkalaemia and axonal dysfunction in
end-stage kidney disease. Clinical
Neurophysiology, 125(1), 179-185. <a
href="http://dx.doi.org/10.1016/j.clinph.2013.06.
022">[More Information]</a>
Devenney, E., Homberger, M., Irish, M., Mioshi,
E., Burrell, J., Tan, R., Kiernan, M., Hodges, J.
(2014). Frontotemporal Dementia Associated
With the C9ORF72 Mutation A Unique Clinical
Profile. JAMA Neurology, 71(3), 331-339. <a
href="http://dx.doi.org/10.1001/jamaneurol.2013
.6002">[More Information]</a>
Bae, J., Yuki, N., Kuwabara, S., Kim, J., Vucic,
S., Lin, C., Kiernan, M. (2014). Guillain-Barré
syndrome in Asia. Journal of Neurology,
Neurosurgery and Psychiatry, 85(8), 905-911. <a
href="http://dx.doi.org/10.1136/jnnp-2013-30621
2">[More Information]</a>
Geevasinga, N., Menon, P., Kiernan, M., Vucic,
S. (2014). Motor cortical function and the
precision grip. Physiological Reports, 2(12),
1-10. <a
href="http://dx.doi.org/10.14814/phy2.12120">[
More Information]</a>
Menon, P., Kiernan, M., Vucic, S. (2014).
Cortical hyperexcitability of the thenar group of
intrinsic hand muscles may contribute to the
split-hand sign in ALS. Clinical
Neurophysiology, 125(4), e1-e7. <a
href="http://dx.doi.org/10.1016/j.clinph.2013.10.
023">[More Information]</a>
Mioshi, E., Caga, J., Lillo, P., Hsieh, S., Ramsey,
E., Devenney, E., Hornberger, M., Hodges, J.,
Kiernan, M. (2014). Neuropsychiatric changes
precede classic motor symptoms in ALS and do
not affect survival. Neurology, 82(2), 149-155.
<a
href="http://dx.doi.org/10.1212/WNL.00000000
00000023">[More Information]</a>
Geevasinga, N., Menon, P., Yiannikas, C.,
Kiernan, M., Vucic, S. (2014). Diagnostic utility
of cortical excitability studies in amyotrophic
Park, S., Kwok, J., Loy, C., Friedlander, M., Lin,
C., Krishnan, A., Lewis, C., Kiernan, M. (2014).
Paclitaxel-induced neuropathy: potential
Publications for Matthew Kiernan
association of MAPT and GSK3B genotypes.
BMC Cancer, 14, 1-5. <a
href="http://dx.doi.org/10.1186/1471-2407-14-9
93">[More Information]</a>
Simon, N., Lomen-Hoerth, C., Kiernan, M.
(2014). Patterns of clinical and electrodiagnostic
abnormalities in early amyotrophic lateral
sclerosis. Muscle and Nerve, 50(6), 894-899. <a
href="http://dx.doi.org/10.1002/mus.24244">[M
ore Information]</a>
Simon, N., Turner, M., Vucic, S., Al-Chalabi, A.,
Shefner, J., Lomen-Hoerth, C., Kiernan, M.
(2014). Quantifying disease progression in
amyotrophic lateral sclerosis. Annals of
Neurology, 76(5), 643-657. <a
href="http://dx.doi.org/10.1002/ana.24273">[Mo
re Information]</a>
Kiernan, M. (2014). Remembrance of things
future. Journal of Neurology, Neurosurgery, and
Psychiatry, 85(1), 1-1. <a
href="http://dx.doi.org/10.1136/jnnp-2013-30712
9">[More Information]</a>
Huynh, W., Kiernan, M. (2014). Reply:
Botulinum toxin injection for post-stroke
spasticity. Muscle and Nerve, 49(6), 932-933. <a
href="http://dx.doi.org/10.1002/mus.24221">[M
ore Information]</a>
Devine, M., Kiernan, M., Heggie, S., McCombe,
P., Henderson, R. (2014). Study of motor
asymmetry in ALS indicates an effect of limb
dominance on onset and spread of weakness, and
an important role for upper motor neurons.
Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 15(7-8), 481-487.
<a
href="http://dx.doi.org/10.3109/21678421.2014.
90661">[More Information]</a>
Ahmed, R., MacMillan, M., Bartley, L.,
Halliday, G., Kiernan, M., Hodges, J., Piguet, O.
(2014). Systemic metabolism in frontotemporal
dementia. Neurology, 83, 1812-1818. <a
href="http://dx.doi.org/10.1212/WNL.00000000
00000993">[More Information]</a>
Huynh, W., Lin, C., Krishnan, A., Vucic, S.,
Kiernan, M. (2014). Transynaptic changes
evident in peripheral axonal function after acute
cerebellar infarct. Cerebellum, 13(6), 669-676.
<a
href="http://dx.doi.org/10.1007/s12311-014-057
7-0">[More Information]</a>
Lee, M., Lance, J., Burke, D., Fitzpatrick, R.,
Simon, N., Kiernan, M. (2014).
Vibration-induced H-reflex inhibition is
suppressed in ALS – A biomarker for upper
motor neuron dysfunction? International
Motoneuron Meeting, Canada.
Lee, M., Lance, J., Burke, D., Fitzpatrick, R.,
Simon, N., Kiernan, M. (2014).
Vibration-induced H-reflex inhibition is
suppressed in ALS – A biomarker for upper
motor neuron dysfunction? 25th International
ALS/MND Symposium.
2013
Vucic, S., Nicholson, G., Chio, A., Kiernan, M.
(2013). Apparent anticipation in SOD1 familial
amyotrophic lateral sclerosis. Amyotrophic
Lateral Sclerosis and Frontotemporal
Degeneration, 14(5), 452-456. <a
href="http://dx.doi.org/10.3109/21678421.2013.
764569">[More Information]</a>
Arnold, R., Kwai, N., Lin, C., Poynten, A.,
Kiernan, M., Krishnan, A. (2013). Axonal
dysfunction prior to neuropathy onset in type 1
diabetes. Diabetes/Metabolism Research and
Reviews, 29(1), 53-59. <a
href="http://dx.doi.org/10.1002/dmrr.2360">[Mo
re Information]</a>
Huynh, W., Krishnan, A., Lin, C., Vucic, S.,
Katrak, P., Hornberger, M., Kiernan, M. (2013).
Botulinum Toxin Modulates Cortical
Maladaptation In Post-Stroke Spasticity. Muscle
and Nerve, 48(1), 93-99. <a
href="http://dx.doi.org/10.1002/mus.23719">[M
ore Information]</a>
Park, S., Goldstein, D., Krishnan, A., Lin, C.,
Friedlander, M., Cassidy, J., Koltzenburg, M.,
Kiernan, M. (2013). Chemotherapy-induced
peripheral neurotoxicity: A critical analysis. CA:
A Cancer Journal for Clinicians, 63(6), 419-437.
<a
href="http://dx.doi.org/10.1002/caac.21204">[M
ore Information]</a>
Mioshi, E., Lillo, P., Hseih, S., Savage, S.,
Hodges, J., Kiernan, M., Hornberger, M. (2013).
Cortical atrophy in ALS is critically associated
with neuropsychiatric and cognitive changes.
Neurology, 80(12), 1117-1123. <a
href="http://dx.doi.org/10.1212/WNL.0b013e31
828869da">[More Information]</a>
Bae, J., Menon, P., Mioshi, E., Kiernan, M.,
Vucic, S. (2013). Cortical excitability differences
between flexor pollicis longus and APB.
Neuroscience Letters, 541, 150-154. <a
href="http://dx.doi.org/10.1016/j.neulet.2013.03.
003">[More Information]</a>
Brodtmann, A., Kiernan, M. (2013). Diagnostic
shifts in ALS? From clinical specter to imaging
spectra. Neurology, 80(7), 606-607. <a
href="http://dx.doi.org/10.1212/WNL.0b013e31
8281cd27">[More Information]</a>
Burrell, J., Carpenter, R., Hodges, J., Kiernan,
M. (2013). Early saccades in amyotrophic lateral
sclerosis. Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 14(4), 294-301.
Publications for Matthew Kiernan
<a
href="http://dx.doi.org/10.3109/21678421.2013.
783077">[More Information]</a>
Kwai, N., Arnold, R., Wickremaarachchi, C.,
Lin, C., Poynten, A., Kiernan, M., Krishnan, A.
(2013). Effects of Axonal Ion Channel
Dysfunction on Quality of Life in Type 2
Diabetes. Diabetes Care, 36(5), 1272-1277. <a
href="http://dx.doi.org/10.2337/dc12-1310">[M
ore Information]</a>
Arnold, R., Pussell, B., Pianta, T., Grinius, V.,
Lin, C., Kiernan, M., Howells, J., Jardine, M.,
Krishnan, A. (2013). Effects of hemodiafiltration
and high flux hemodialysis on nerve excitability
in end-stage kidney disease. PloS One, 8(3), 1-8.
<a
href="http://dx.doi.org/10.1371/journal.pone.005
9055">[More Information]</a>
Farrar, M., Park, S., Lin, C., Kiernan, M. (2013).
Evolution of peripheral nerve function in
humans: novel insights from motor nerve
excitability. The Journal of Physiology, 591(Pt
1), 273-286. <a
href="http://dx.doi.org/10.1113/jphysiol.2012.24
0820">[More Information]</a>
Simon, N., Kiernan, M. (2013). Fasciculation
anxiety syndrome in clinicians. Journal of
Neurology, 260(7), 1743-1747. <a
href="http://dx.doi.org/10.1007/s00415-013-685
6-8">[More Information]</a>
Kiernan, M. (2013). Lies, damned lies.. and
citation metrics. Journal of Neurology,
Neurosurgery, and Psychiatry, 84(1), 1-1. <a
href="http://dx.doi.org/10.1136/jnnp-2012-30448
8">[More Information]</a>
Huynh, W., Vucic, S., Krishnan, A., Lin, C.,
Hornberger, M., Kiernan, M. (2013).
Longitudinal Plasticity Across the Neural Axis in
Acute Stroke. Neurorehabilitation and Neural
Repair, 27(3), 219-229. <a
href="http://dx.doi.org/10.1177/1545968312462
071">[More Information]</a>
Huynh, W., Krishnan, A., Vucic, S., Lin, C.,
Kiernan, M. (2013). Motor Cortex Excitability in
Acute Cerebellar Infarct. Cerebellum, 12(6),
826-834. <a
href="http://dx.doi.org/10.1007/s12311-013-049
3-8">[More Information]</a>
Simon, N., Reddel, S., Kiernan, M., Layzer, R.
(2013). Muscle-specific kinase antibodies: A
novel cause of peripheral nerve
hyperexcitability? Muscle and Nerve, 48(5),
819-823. <a
href="http://dx.doi.org/10.1002/mus.23907">[M
ore Information]</a>
Farrar, M., Vucic, S., Johnston, H., du Sart, D.,
Kiernan, M. (2013). Pathophysiological Insights
Derived by Natural History and Motor Function
of Spinal Muscular Atrophy. The Journal of
Pediatrics, 162(1), 155-159. <a
href="http://dx.doi.org/10.1016/j.jpeds.2012.05.0
67">[More Information]</a>
Williams, K., Fifita, J., Vucic, S., Durnall, J.,
Kiernan, M., Blair, I., Nicholson, G. (2013).
Pathophysiological insights into ALS with
C9ORF72 expansions. Journal of Neurology,
Neurosurgery, and Psychiatry, 84(8), 931-935.
<a
href="http://dx.doi.org/10.1136/jnnp-2012-30452
9">[More Information]</a>
Menezes, M., Farrar, M., Burns, J., Menon, P.,
Webster, R., Antony, J., Kiernan, M., Vucic, S.
(2013). Peripheral motor contributions to the
pathophysiology of BVVL-related mutations in
riboflavin transporter 3: Pathophysiological
insights from nerve excitability testing. 2013
Meeting of the Peripheral Nerve Society, USA:
Wiley-Blackwell Publishing, Inc.
Kiernan, M., Kaji, R. (2013). Physiology and
pathophysiology of myelinated nerve fibers. In
Gerard Said and Christian Krarup (Eds.),
Handbook of Clinical Neurology: Vol 115
Peripheral Nerve Disorders, (pp. 43-53).
Amsterdam: Elsevier.
Vucic, S., Lin, C., Cheah, B., Murray, J., Menon,
P., Krishnan, A., Kiernan, M. (2013). Riluzole
exerts central and peripheral modulating effects
in amyotrophic lateral sclerosis. Brain, 136(5),
1361-1370. <a
href="http://dx.doi.org/10.1093/brain/awt085">[
More Information]</a>
Menon, P., Kiernan, M., Yiannikas, C., Stroud,
J., Vucic, S. (2013). Split-hand index for the
diagnosis of amyotrophic lateral sclerosis.
Clinical Neurophysiology, 124(2), 410-416. <a
href="http://dx.doi.org/10.1016/j.clinph.2012.07.
025">[More Information]</a>
Menon, P., Bae, J., Mioshi, E., Kiernan, M.,
Vucic, S. (2013). Split-hand plus sign in ALS:
Differential involvement of the flexor pollicis
longus and intrinsic hand muscles. Amyotrophic
Lateral Sclerosis and Frontotemporal
Degeneration, 14(4), 315-318. <a
href="http://dx.doi.org/10.3109/21678421.2012.
734521">[More Information]</a>
Krishnan, A., Kiernan, M. (2013).
Sustained-release fampridine and the role of ion
channel dysfunction in multiple sclerosis.
Multiple Sclerosis Journal, 19(4), 385-391. <a
href="http://dx.doi.org/10.1177/1352458512463
769">[More Information]</a>
Bae, J., Simon, N., Menon, P., Vucic, S.,
Kiernan, M. (2013). The Puzzling Case of
Hyperexcitability in Amyotrophic Lateral
Publications for Matthew Kiernan
Sclerosis. Journal of Clinical Neurology, 9(2),
65-74. <a
href="http://dx.doi.org/10.3988/jcn.2013.9.2.65"
>[More Information]</a>
peroneal neuropathy and cancer. Internal
Medicine Journal, 42(7), 837-840. <a
href="http://dx.doi.org/10.1111/j.1445-5994.201
2.02836.x">[More Information]</a>
Vucic, S., Ziemann, U., Eisen, A., Hallett, M.,
Kiernan, M. (2013). Transcranial magnetic
stimulation and amyotrophic lateral sclerosis:
Pathophysiological insights. Journal of
Neurology, Neurosurgery and Psychiatry,
84(10), 1161-1170. <a
href="http://dx.doi.org/10.1136/jnnp-2012-30401
9">[More Information]</a>
Vucic, S., Burke, T., Lenton, K., Ramanathan,
S., Gomes, L., Yannikas, C., Kiernan, M. (2012).
Cortical dysfunction underlies disability in
multiple sclerosis. Multiple Sclerosis Journal,
18(4), 425-432. <a
href="http://dx.doi.org/10.1177/1352458511424
308">[More Information]</a>
Vucic, S., Kiernan, M. (2013). Utility of
transcranial magnetic stimulation in delineating
amyotrophic lateral sclerosis pathophysiology.
In Andres M. Lozano, Mark Hallett (Eds.),
Handbook of Clinical Neurology: Brain
Stimulation, (pp. 561-575). Amsterdam: Elsevier
B.V.
Hogden, A., Greenfield, D., Nugus, P., Kiernan,
M. (2013). What are the roles of carers in
decision-making for amyotrophic lateral sclerosis
multidisciplinary care? Patient Preference and
Adherence, 7, 171-181. <a
href="http://dx.doi.org/10.2147/PPA.S40783">[
More Information]</a>
Hseih, S., Lillo, P., Kiernan, M., Hodges, J.,
Mioshi, E. (2013). When more is needed: the
utility of the frontotemporal dementia scale in
ALS. Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 14(3), 169-171.
<a
href="http://dx.doi.org/10.3109/21678421.2013.
764899">[More Information]</a>
2012
Mioshi, E., Lillo, P., Kiernan, M., Hodges, J.
(2012). Activities of daily living in motor neuron
disease: role of behavioural and motor changes.
Journal of Clinical Neuroscience, 19(4),
552-556. <a
href="http://dx.doi.org/10.1016/j.jocn.2011.07.0
42">[More Information]</a>
Kiernan, M. (2012). Amyotrophic lateral
sclerosis and frontotemporal dementia. Journal
of Neurology, Neurosurgery and Psychiatry,
83(4), 355. <a
href="http://dx.doi.org/10.1136/jnnp-2012-30235
7">[More Information]</a>
Lillo, P., Savage, S., Mioshi, E., Kiernan, M.,
Hodges, J. (2012). Amyotrophic lateral sclerosis
and frontotemporal dementia: A behavioural and
cognitive continuum. Amyotrophic Lateral
Sclerosis and Frontotemporal Degeneration,
13(1), 102-109. <a
href="http://dx.doi.org/10.3109/17482968.2011.
639376">[More Information]</a>
Simon, N., Kiernan, M. (2012). Common
Farrar, M., Vucic, S., Johnston, H., Kiernan, M.
(2012). Corticomotoneuronal Integrity and
Adaptation in Spinal Muscular Atrophy. JAMA
Neurology, 69(4), 467-473. <a
href="http://dx.doi.org/10.1001/archneurol.2011.
1697">[More Information]</a>
Turner, M., Kiernan, M. (2012). Does
interneuronal dysfunction contribute to
neurodegeneration in amyotrophic lateral
sclerosis? Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 13(3), 245-250.
<a
href="http://dx.doi.org/10.3109/17482968.2011.
636050">[More Information]</a>
Kiernan, M. (2012). Emergence of a predictive
clinical biomarker for diabetic neuropathy.
Diabetes, 61(6), 1346-1347. <a
href="http://dx.doi.org/10.2337/db12-0193">[M
ore Information]</a>
Hogden, A., Greenfield, D., Nugus, P., Kiernan,
M. (2012). Engaging in patient decision-making
in multidisciplinary care for amyotrophic lateral
sclerosis: the views of health professionals.
Patient Preference and Adherence, 6, 691-701.
<a
href="http://dx.doi.org/10.2147/PPA.S36759">[
More Information]</a>
Vucic, S., Stein, T., Hedley-Whyte, E., Reddel,
S., Tisch, S., Kotschet, K., Cros, D., Kiernan, M.
(2012). FOSMN syndrome: Novel insight into
disease pathophysiology. Neurology, 79(1),
73-79. <a
href="http://dx.doi.org/10.1212/WNL.0b013e31
825dce13">[More Information]</a>
Lillo, P., Mioshi, E., Burrell, J., Kiernan, M.,
Hodges, J., Hornberger, M. (2012). Grey and
White Matter Changes across the Amyotrophic
Lateral Sclerosis-Frontotemporal Dementia
Continuum. PloS One, 7(8), 1-10. <a
href="http://dx.doi.org/10.1371/journal.pone.004
3993">[More Information]</a>
Hunter, M., Kiernan, M., Post, J. (2012). Human
T-lymphotropic virus seroconversion associated
with pooled human intravenous immunoglobulin
therapy. Internal Medicine Journal, 42(6),
729-730. <a
Publications for Matthew Kiernan
href="http://dx.doi.org/10.1111/j.1445-5994.201
2.02803.x">[More Information]</a>
Kiernan, M., Petri, S. (2012). Hyperexcitability
and amyotrophic lateral sclerosis. Neurology,
78(20), 1544-1545. <a
href="http://dx.doi.org/10.1212/WNL.0b013e31
82563c0a">[More Information]</a>
Bennett, B., Park, S., Lin, C., Friedlander, M.,
Kiernan, M., Goldstein, D. (2012). Impact of
oxaliplatin-induced neuropathy: a patient
perspective. Supportive Care in Cancer, 20(11),
2959-2967. <a
href="http://dx.doi.org/10.1007/s00520-012-142
8-5">[More Information]</a>
Krishnan, A., Park, S., Huynh, W., Lin, C.,
Henderson, R., Kiernan, M. (2012). Impaired
energy-dependent processes underlie acute lead
neuropathy. Muscle and Nerve, 46(6), 954-956.
<a
href="http://dx.doi.org/10.1002/mus.23425">[M
ore Information]</a>
Menezes, M., Waddell, L., Evesson, F., Cooper,
S., Webster, R., Jones, K., Mowat, D., Kiernan,
M., Johnston, H., Corbett, A., North, K., Clarke,
N., et al (2012). Importance and challenge of
making an early diagnosis in LMNA-related
muscular dystrophy. Neurology, 78(16),
1258-1263. <a
href="http://dx.doi.org/10.1212/WNL.0b013e31
8250d839">[More Information]</a>
Tomlinson, S., Bostock, H., Grinton, B., Hanna,
M., Kullmann, D., Kiernan, M., Scheffer, I.,
Berkovic, S., Burke, D. (2012). In vivo loss of
slow potassium channel activity in individuals
with benign familial neonatal epilepsy in
remission. Brain, 135, 3144-3152. <a
href="http://dx.doi.org/10.1093/brain/aws241">[
More Information]</a>
Amirjani, N., Kiernan, M., McKenzie, D., Butler,
J., Gandevia, S. (2012). Is there a case for
diaphragm pacing for amyotrophic lateral
sclerosis patients? Amyotrophic Lateral Sclerosis
and Frontotemporal Degeneration, 13(6),
521-527. <a
href="http://dx.doi.org/10.3109/17482968.2012.
673169">[More Information]</a>
Park, S., Lin, C., Kiernan, M., Koltzenburg, M.
(2012). Longitudinal assessment of
oxaliplatin-induced neuropathy. Neurology,
78(2), 152. <a
href="http://dx.doi.org/10.1212/01.wnl.0000410
913.88642.bf">[More Information]</a>
Kiernan, M. (2012). Movement disorders: what
lies beneath? Journal of Neurology,
Neurosurgery and Psychiatry, 83(10), 949. <a
href="http://dx.doi.org/10.1136/jnnp-2012-30375
8">[More Information]</a>
Park, S., Lin, C., Kiernan, M. (2012). Nerve
Excitability Assessment in
Chemotherapy-induced Neurotoxicity. Journal of
Visualized Experiments, 62, 3439. <a
href="http://dx.doi.org/10.3791/3439">[More
Information]</a>
Cheah, B., Lin, C., Park, S., Vucic, S., Krishnan,
A., Kiernan, M. (2012). Progressive axonal
dysfunction and clinical impairment in
amyotrophic lateral sclerosis. Clinical
Neurophysiology, 123(12), 2460-2467. <a
href="http://dx.doi.org/10.1016/j.clinph.2012.06.
020">[More Information]</a>
Burrell, J., Homberger, M., Carpenter, R.,
Kiernan, M., Hodges, J. (2012). Saccadic
abnormalities in frontotemporal dementia.
Neurology, 78(23), 1816-1823. <a
href="http://dx.doi.org/10.1212/WNL.0b013e31
8258f75c">[More Information]</a>
Kim, S., Vucic, S., Mahant, N., Kiernan, M.,
Fung, V. (2012). The relationship between
cortical and spinal hyperexcitability and clinical
disease severity in stiff-man syndrome.
Parkinsonism & Related Disorders, 18(9),
1045-1047. <a
href="http://dx.doi.org/10.1016/j.parkreldis.2012
.04.022">[More Information]</a>
Ahmadzai, H., Kiernan, M., Wakefield, D.,
Thomas, P. (2012). Treatment of refractory
neurosarcoidosis with TNF-inhibitors: what lies
ahead? Internal Medicine Journal, 42(2), 232. <a
href="http://dx.doi.org/10.1111/j.1445-5994.201
1.02576.x">[More Information]</a>
Hogden, A., Greenfield, D., Nugus, P., Kiernan,
M. (2012). What influences patient
decision-making in amyotrophic lateral sclerosis
multidisciplinary care? A study of patient
perspectives. Patient Preference and Adherence,
6, 829-838. <a
href="http://dx.doi.org/10.2147/PPA.S37851">[
More Information]</a>
Kiernan, M. (2012). What is impact? Journal of
Neurology, Neurosurgery and Psychiatry, 83(1),
1-2. <a
href="http://dx.doi.org/10.1136/jnnp-2011-30173
8">[More Information]</a>
2011
Park, S., Lin, C., Burke, D., Kiernan, M. (2011).
Activity-dependent conduction failure: molecular
insights. Journal of the Peripheral Nervous
System, 16(3), 159-168. <a
href="http://dx.doi.org/10.1111/j.1529-8027.201
1.00358.x">[More Information]</a>
Boland, R., Lin, C., Engel, S., Kiernan, M.
(2011). Adaptation of motor function after spinal
cord injury: novel insights into spinal shock.
Brain, 134(2), 495-505. <a
Publications for Matthew Kiernan
href="http://dx.doi.org/10.1093/brain/awq289">[
More Information]</a>
Kiernan, M., Vucic, S., Cheah, B., Turner, M.,
Eisen, A., Hardiman, O., Burrell, J., Zoing, M.
(2011). Amyotrophic lateral sclerosis. The
Lancet, 377(9769), 942-955. <a
href="http://dx.doi.org/10.1016/S0140-6736(10)
61156-7">[More Information]</a>
Vucic, S., Kiernan, M. (2011). Clarifying
variability of corticomotoneuronal function in
Kennedy disease. Muscle and Nerve, 44(2),
197-201. <a
href="http://dx.doi.org/10.1002/mus.22017">[M
ore Information]</a>
Hardiman, O., van den Berg, L., Kiernan, M.
(2011). Clinical diagnosis and management of
amyotrophic lateral sclerosis. Nature Reviews.
Neurology, 7(11), 639-649. <a
href="http://dx.doi.org/10.1038/nrneurol.2011.15
3">[More Information]</a>
Vucic, S., Cheah, B., Yiannikas, C., Kiernan, M.
(2011). Cortical excitability distinguishes ALS
from mimic disorders. Clinical Neurophysiology,
122(9), 1860-1866. <a
href="http://dx.doi.org/10.1016/j.clinph.2010.12.
062">[More Information]</a>
Park, S., Lin, C., Krishnan, A., Goldstein, D.,
Friedlander, M., Kiernan, M. (2011). Dose
effects of oxaliplatin on persistent and transient
na conductances and the development of
neurotoxicity. PloS One, 6(4), e18469-e18469.
<a
href="http://dx.doi.org/10.1371/journal.pone.001
8469">[More Information]</a>
Farrar, M., Vucic, S., Lin, C., Park, S., Johnston,
H., du Sart, D., Bostock, H., Kiernan, M. (2011).
Dysfunction of axonal membrane conductances
in adolescents and young adults with spinal
muscular atrophy. Brain, 134(11), 3185-3197. <a
href="http://dx.doi.org/10.1093/brain/awr229">[
More Information]</a>
Park, S., Lin, C., Krishnan, A., Friedlander, M.,
Lewis, C., Kiernan, M. (2011). Early,
progressive, and sustained dysfunction of
sensory axons underlies paclitaxel-induced
neuropathy. Muscle and Nerve, 43(3), 367-674.
<a
href="http://dx.doi.org/10.1002/mus.21874">[M
ore Information]</a>
Han, S., Lin, C., Boland, R., Kiernan, M. (2011).
Effects of focal nerve compression on membrane
excitability and symptoms in carpal tunnel
syndrome. APA Physiotherapy Conference 2011,
NA.
Kiernan, M. (2011). Freud, neurology and the
emergence of dynamic neural networks. Journal
of Neurology, Neurosurgery and Psychiatry,
82(2), 120. <a
href="http://dx.doi.org/10.1136/jnnp.2010.22499
8">[More Information]</a>
Lillo, P., Mioshi, E., Zoing, M., Kiernan, M.,
Hodges, J. (2011). How common are behavioural
changes in amyotrophic lateral sclerosis?
Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 12(1), 45-51. <a
href="http://dx.doi.org/10.3109/17482968.2010.
520718">[More Information]</a>
Burrell, J., Vucic, S., Kiernan, M. (2011).
Isolated bulbar phenotype of amyotrophic lateral
sclerosis. Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 12(4), 283-289.
<a
href="http://dx.doi.org/10.3109/17482968.2011.
551940">[More Information]</a>
Park, S., Lin, C., Krishnan, A., Goldstein, D.,
Friedlander, M., Kiernan, M. (2011). Long-Term
Neuropathy After Oxaliplatin Treatment:
Challenging the Dictum of Reversibility. The
Oncologist, 16(5), 708-716. <a
href="http://dx.doi.org/10.1634/theoncologist.20
10-0248">[More Information]</a>
Vucic, S., Cheah, B., Kiernan, M. (2011).
Maladaptation of cortical circuits underlies
fatigue and weakness in ALS. Amyotrophic
Lateral Sclerosis and Frontotemporal
Degeneration, 12(6), 414-420. <a
href="http://dx.doi.org/10.3109/17482968.2011.
597403">[More Information]</a>
Lin, C., Krishnan, A., Park, S., Kiernan, M.
(2011). Modulatory effects on axonal function
after intravenous immunoglobulin therapy in
chronic inflammatory demyelinating
polyneuropathy. JAMA Neurology, 68(7),
862-869. <a
href="http://dx.doi.org/10.1001/archneurol.2011.
137">[More Information]</a>
Burrell, J., Kiernan, M., Vucic, S., Hodges, J.
(2011). Motor Neuron dysfunction in
frontotemporal dementia. Brain, 134(9),
2582-2594. <a
href="http://dx.doi.org/10.1093/brain/awr195">[
More Information]</a>
Zoing, M., Kiernan, M. (2011). Motor neurone
disease - caring for the patient in general
practice. Australian Family Physician, 40(12),
962-966. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=22146323">[More Information]</a>
Han, S., Lin, C., Boland, R., Kiernan, M. (2011).
Nerve compression, membrane excitability, and
symptoms of carpal tunnel syndrome. Muscle
and Nerve, 44(3), 402-409. <a
href="http://dx.doi.org/10.1002/mus.22078">[M
Publications for Matthew Kiernan
ore Information]</a>
Huynh, W., Kiernan, M. (2011). Nerve
conduction studies. Australian Family Physician,
40(9), 693-697. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=21894276">[More Information]</a>
Cheah, B., Vucic, S., Krishnan, A., Boland, R.,
Kiernan, M. (2011). Neurophysiological index as
a biomarker for ALS progression: Validity of
mixed effects models. Amyotrophic Lateral
Sclerosis and Frontotemporal Degeneration,
12(1), 33-38. <a
href="http://dx.doi.org/10.3109/17482968.2010.
531742">[More Information]</a>
Park, S., Goldstein, D., Lin, C., Krishnan, A.,
Friedlander, M., Kiernan, M. (2011).
Neuroprotection for Oxaliplatin-Induced
Neurotoxicity: What Happened to Objective
Assessment? Journal of Clinical Oncology,
29(18), e553-e554. <a
href="http://dx.doi.org/10.1200/JCO.2011.34.82
27">[More Information]</a>
Burrell, J., Yiannikas, C., Rowe, D., Kiernan, M.
(2011). Predicting a positive response to
intravenous immunoglobulin in isolated lower
motor neuron syndromes. PloS One, 6(10),
e27041-e27041. <a
href="http://dx.doi.org/10.1371/journal.pone.002
7041">[More Information]</a>
Lin, C., Lee, M., Park, S., Kiernan, M. (2011).
Purple pigments: The pathophysiology of acute
porphyric neuropathy. Clinical Neurophysiology,
122(12), 2336-2344. <a
href="http://dx.doi.org/10.1016/j.clinph.2011.07.
036">[More Information]</a>
Krishnan, A., Park, S., Payne, M., Lin, C., Vucic,
S., Kiernan, M. (2011). Regional differences in
ulnar nerve excitability may predispose to the
development of entrapment neuropathy. Clinical
Neurophysiology, 122(1), 194-198. <a
href="http://dx.doi.org/10.1016/j.clinph.2010.04.
038">[More Information]</a>
Park, S., Lin, C., Krishnan, A., Kiernan, M.
(2011). The contribution of SK3 polymorphisms
to acute oxaliplatin-induced neurotoxicity: direct
or indirect effects? Cancer Chemotherapy and
Pharmacology, 67(5), 1189-1190. <a
href="http://dx.doi.org/10.1007/s00280-011-157
9-y">[More Information]</a>
Huynh, W., Krishnan, A., Lin, C., Vucic, S.,
Kiernan, M. (2011). The effects of large artery
ischemia and subsequent recanalization on nerve
excitability. Muscle and Nerve, 44(5), 841. <a
href="http://dx.doi.org/10.1002/mus.22209">[M
ore Information]</a>
Kiernan, M. (2011). The realm of neurology -
past, present and future. Journal of Neurology,
Neurosurgery and Psychiatry, 82(1), 1. <a
href="http://dx.doi.org/10.1136/jnnp.2010.23434
4">[More Information]</a>
Park, S., Lin, C., Krishnan, A., Goldstein, D.,
Friedlander, M., Kiernan, M. (2011). Utilising
natural activity to dissect the Pathophysiology of
acute oxaliplatin-induced neuropathy.
Experimental Neurology, 227(1), 120-127. <a
href="http://dx.doi.org/10.1016/j.expneurol.2010
.10.002">[More Information]</a>
Carson, A., Kiernan, M. (2011). Who is really
the world's best known neurologist? Practical
Neurology, 11(6), 380-381. <a
href="http://dx.doi.org/10.1136/practneurol-2011
-000141">[More Information]</a>
2010
Farrar, M., Lin, C., Krishnan, A., Park, S.,
Andrews, P., Kiernan, M. (2010). Acute,
Reversible Axonal Energy Failure During
Stroke-Like Episodes in MELAS. Pediatrics,
126(3), e734-e739. <a
href="http://dx.doi.org/10.1542/peds.2009-2930"
>[More Information]</a>
Han, S., Lin, C., Borland, R., Bilston, L.,
Kiernan, M. (2010). Changes in human sensory
axonal excitability induced by focal nerve
compression. The Journal of Physiology,
588(10), 1737-1745. <a
href="http://dx.doi.org/10.1113/jphysiol.2010.18
8169">[More Information]</a>
Vucic, S., Nicholson, G., Kiernan, M. (2010).
Cortical excitability in hereditary motor
neuronopathy with pyramidal signs: comparison
with ALS. Journal of Neurology, Neurosurgery
and Psychiatry, 81(1), 97-100. <a
href="http://dx.doi.org/10.1136/jnnp.2008.15753
7">[More Information]</a>
Vucic, S., Cheah, B., Yiannikas, C., Vincent, A.,
Kiernan, M. (2010). Corticomotoneuronal
function and hyperexcitability in acquired
neuromyotonia. Brain, 133(9), 2727-2733. <a
href="http://dx.doi.org/10.1093/brain/awq188">[
More Information]</a>
Vucic, S., Winhammar, J., Rowe, D., Kiernan,
M. (2010). Corticomotoneuronal function in
asymptomatic SOD-1 mutation carriers. Clinical
Neurophysiology, 121(10), 1781-1785. <a
href="http://dx.doi.org/10.1016/j.clinph.2010.02.
164">[More Information]</a>
Huynh, W., Lam, A., Vucic, S., Cheah, B.,
Clouston, P., Kiernan, M. (2010). Corticospinal
tract dysfunction and development of
amyotrophic lateral sclerosis following electrical
injury. Muscle and Nerve, 42(2), 288-292. <a
href="http://dx.doi.org/10.1002/mus.21681">[M
ore Information]</a>
Publications for Matthew Kiernan
Cheah, B., Kiernan, M. (2010). Dexpramipexole,
the R(+) enantiomer of pramipexole, for the
potential treatment of amyotrophic lateral
sclerosis. IDrugs : the investigational drugs
journal, 13(12), 911-920. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=21154151">[More Information]</a>
Vucic, S., Cheah, B., Kiernan, M. (2010).
Dissecting the Mechanisms Underlying
Short-Interval Intracortical Inhibition Using
Exercise. Cerebral Cortex, , 1-6. <a
href="http://dx.doi.org/10.1093/cercor/bhq235">
[More Information]</a>
Vucic, S., Burke, D., Kiernan, M. (2010).
Fatigue in Multiple Sclerosis: Mechanisms and
Management. Clinical Neurophysiology, 121(6),
809-817. <a
href="http://dx.doi.org/10.1016/j.clinph.2009.12.
013">[More Information]</a>
Blair, I., Williams, K., Warraich, S., Durnall, J.,
Thoeng, A., Manavis, J., Blumbergs, P., Vucic,
S., Kiernan, M., Nicholson, G. (2010). FUS
mutations in amyotrophic lateral sclerosis:
clinical, pathological, neurophysiological and
genetic analysis. Journal of Neurology,
Neurosurgery and Psychiatry, 81(6), 639-645. <a
href="http://dx.doi.org/10.1136/jnnp.2009.19439
9">[More Information]</a>
Cheah, B., Kiernan, M. (2010).
Neurophysiological methodologies: diagnosis of
peripheral nerve disease and assessment of
pharmacological agents. Current Opinion in
Investigational Drugs (Print), 11(1), 72-79. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=20047161">[More Information]</a>
Cheah, B., Vucic, S., Krishnan, A., Kiernan, M.
(2010). Riluzole, Neuroprotection and
Amyotrophic Lateral Sclerosis. Current
Medicinal Chemistry, 17(18), 1942-1959. <a
href="http://dx.doi.org/10.2174/0929867107911
63939">[More Information]</a>
He, E., Wang, L., Kiernan, M. (2010). Scurvy
and stroke - is there an association? Medical
Journal of Australia, 193(9), 555-556. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=21034393">[More Information]</a>
Inam, S., Vucic, S., Brodaty, N., Zoing, M.,
Kiernan, M. (2010). The 10-metre gait speed as a
functional biomarker in amyotrophic lateral
sclerosis. Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 11(6), 558-561.
<a
href="http://dx.doi.org/10.3109/1748296100379
2958">[More Information]</a>
Loy, C., Kril, J., Trollor, J., Kiernan, M., Kwok,
J., Vucic, S., Halliday, G., Hodges, J. (2010).
The case of a 48 year-old woman with bizarre
and complex delusions. Nature Reviews
Neurology, 6(3), 175-179. <a
href="http://dx.doi.org/10.1038/nrneurol.2010.3"
>[More Information]</a>
Vucic, S., Kiernan, M. (2010). Upregulation of
persistent sodium conductances in familial ALS.
Journal of Neurology, Neurosurgery and
Psychiatry, 81(2), 222-227. <a
href="http://dx.doi.org/10.1136/jnnp.2009.18307
9">[More Information]</a>
Kiernan, M. (2010). Why an Australian editor for
JNNP? Journal of Neurology, Neurosurgery and
Psychiatry, 81(1), 1-1. <a
href="http://dx.doi.org/10.1136/jnnp.2009.20006
3">[More Information]</a>
2009
Park, S., Goldstein, D., Lin, C., Krishnan, A.,
Friedlander, M., Kiernan, M. (2009). Acute
abnormalities of sensory nerve function
associated with oxaliplatin-induced
neurotoxicity. Journal of Clinical Oncology,
27(8), 1243-1249. <a
href="http://dx.doi.org/10.1200/JCO.2008.19.34
25">[More Information]</a>
Kiernan, M. (2009). Amyotrophic lateral
sclerosis and the neuroprotective potential of
exercise. The Journal of Physiology, 587(15),
3759-3760. <a
href="http://dx.doi.org/10.1113/jphysiol.2009.17
7022">[More Information]</a>
Boland, R., Kiernan, M. (2009). Assessing the
accuracy of a combination of clinical tests for
identifying carpal tunnel syndrome. Journal of
Clinical Neuroscience, 16(7), 929-933. <a
href="http://dx.doi.org/10.1016/j.jocn.2008.09.0
04">[More Information]</a>
Krishnan, A., Lin, C., Park, S., Kiernan, M.
(2009). Axonal ion channels from bench to
bedside: a translational neuroscience perspective.
Progress in Neurobiology, 89(3), 288-313. <a
href="http://dx.doi.org/10.1016/j.pneurobio.2009
.08.002">[More Information]</a>
Turner, M., Kiernan, M., Leigh, P., Talbot, K.
(2009). Biomarkers in amyotrophic lateral
sclerosis. Lancet Neurology, 8(1), 94-109. <a
href="http://dx.doi.org/10.1016/S1474-4422(08)
70293-X">[More Information]</a>
Krishnan, A., Lin, C., Reddel, S., McGrath, R.,
Kiernan, M. (2009). Conduction block and
impaired axonal function in tick paralysis.
Muscle and Nerve, 40(3), 358-362. <a
href="http://dx.doi.org/10.1002/mus.21395">[M
ore Information]</a>
Publications for Matthew Kiernan
Nogajski, J., Kiernan, M., Ouvrier, R., Andrews,
P. (2009). Congenital myasthenic syndromes.
Journal of Clinical Neuroscience, 16(1), 1-11. <a
href="http://dx.doi.org/10.1016/j.jocn.2008.05.0
01">[More Information]</a>
Vucic, S., Cheah, B., Kiernan, M. (2009).
Defining the mechanisms that underlie cortical
hyperexcitability in amyotrophic lateral sclerosis.
Experimental Neurology, 220(1), 177-182. <a
href="http://dx.doi.org/10.1016/j.expneurol.2009
.08.017">[More Information]</a>
Vucic, S., Kiernan, M., Cornblath, D. (2009).
Guillain-Barré syndrome: An Update. Journal of
Clinical Neuroscience, 16(6), 733-741. <a
href="http://dx.doi.org/10.1016/j.jocn.2008.08.0
33">[More Information]</a>
Kiernan, M. (2009). Hyperexcitability, persistent
Na+ conductances and neurodegeneration in
amyotrophic lateral sclerosis. Experimental
Neurology, 218(1), 1-4. <a
href="http://dx.doi.org/10.1016/j.expneurol.2009
.03.039">[More Information]</a>
Kiernan, M. (2009). Identification of cognitive
deficits in amyotrophic lateral sclerosis. Clinical
Neurophysiology, 120(4), 645-646. <a
href="http://dx.doi.org/10.1016/j.clinph.2009.02.
156">[More Information]</a>
Cheah, B., Boland, R., Brodaty, N., Zoing, M.,
Jeffery, S., McKenzie, D., Kiernan, M. (2009).
INSPIRATIonAL - INSPIRAtory muscle
training in amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis and
Frontotemporal Degeneration, 10(5-6), 384-392.
<a
href="http://dx.doi.org/10.3109/1748296090308
2218">[More Information]</a>
Han, S., Boland, R., Krishnan, A., Vucic, S., Lin,
C., Kiernan, M. (2009). Ischaemic sensitivity of
axons in carpal tunnel syndrome. Journal of the
Peripheral Nervous System, 14(3), 190-200. <a
href="http://dx.doi.org/10.1111/j.1529-8027.200
9.00231.x">[More Information]</a>
Barritt, A., Basci, A., Tschuchnigg, M., Sharpe,
D., Kiernan, M. (2009). Myasthenia gravis seven
years after removal of an invasive thymoma.
Journal of Clinical Neuroscience, 16(7),
966-968. <a
href="http://dx.doi.org/10.1016/j.jocn.2008.09.0
16">[More Information]</a>
Kiernan, M., Krishnan, A. (2009). Neurological
complications of chronic kidney disease. Nature
Reviews. Neurology, 5(10), 542-551. <a
href="http://dx.doi.org/10.1038/nrneurol.2009.13
8">[More Information]</a>
Krishnan, A., Pussell, B., Kiernan, M. (2009).
Neuromuscular disease in the dialysis patient: an
update for the nephrologist. Seminars in Dialysis,
22(3), 267-278. <a
href="http://dx.doi.org/10.1111/j.1525-139X.200
8.00555.x">[More Information]</a>
Park, S., Lin, C., Krishnan, A., Goldstein, D.,
Friedlander, M., Kiernan, M. (2009).
Oxaliplatin-Induced Lhermitte's Phenomenon as
a Manifestation of Severe Generalized
Neurotoxicity. Neuro-Oncology, 77(6), 342-348.
<a
href="http://dx.doi.org/10.1159/000265940">[M
ore Information]</a>
Park, S., Lin, C., Krishnan, A., Goldstein, D.,
Friedlander, M., Kiernan, M. (2009).
Oxaliplatin-induced neurotoxicity: changes in
axonal excitability precede development of
neuropathy. Brain, 132(10), 2712-2723. <a
href="http://dx.doi.org/10.1093/brain/awp219">[
More Information]</a>
Vucic, S., Kiernan, M. (2009). Pathophysiology
of neurodegeneration in familial amyotrophic
lateral sclerosis. Current Molecular Medicine,
9(3), 255-272. <a
href="http://dx.doi.org/10.2174/1566524097878
47173">[More Information]</a>
Boland, R., Bostock, H., Kiernan, M. (2009).
Plasticity of lower limb motor axons after
cervical cord injury. Clinical Neurophysiology,
120(1), 204-209. <a
href="http://dx.doi.org/10.1016/j.clinph.2008.10.
009">[More Information]</a>
Farrar, M., Johnston, H., Grattan-Smith, P.,
Turner, A., Kiernan, M. (2009). Spinal muscular
atrophy: molecular mechanisms. Current
Molecular Medicine, 9(7), 851-862. <a
href="http://dx.doi.org/10.2174/1566524097891
05516">[More Information]</a>
Burke, D., Howells, J., Trevillion, L., McNulty,
P., Jankelowitz, S., Kiernan, M. (2009).
Threshold behaviour of human axons explored
using subthreshold perturbations to membrane
potential. The Journal of Physiology, 587(2),
491-504. <a
href="http://dx.doi.org/10.1113/jphysiol.2008.16
3170">[More Information]</a>
2008
Krishnan, A., Lin, C., Kiernan, M. (2008).
Activity-dependent excitability changes suggest
Na+/K+ pump dysfunction in diabetic
neuropathy. Brain, 131(Pt 5), 1209-1216. <a
href="http://dx.doi.org/10.1093/brain/awn052">[
More Information]</a>
Nguyen-Lam, J., Kiernan, M. (2008). Acute
cortical blindness due to posterior reversible
encephalopathy. Journal of Clinical
Neuroscience, 15(10), 1182-1185. <a
href="http://dx.doi.org/10.1016/j.jocn.2007.04.0
25">[More Information]</a>
Publications for Matthew Kiernan
Krishnan, A., Lin, C., Park, S., Kiernan, M.
(2008). Assessment of nerve excitability in toxic
and metabolic neuropathies. Journal of the
Peripheral Nervous System, 13(1), 7-26. <a
href="http://dx.doi.org/10.1111/j.1529-8027.200
8.00155.x">[More Information]</a>
Krishnan, A., Bostock, H., IP, J., Hayes, M.,
Watson, S., Kiernan, M. (2008). Axonal function
in a family with episodic ataxia type 2 due to a
novel mutation. Journal of Neurology, 255(5),
750-755. <a
href="http://dx.doi.org/10.1007/s00415-008-079
4-x">[More Information]</a>
Bacsi, A., Kiernan, M. (2008). Changes in
axonal excitability and burst pattern behaviour in
synkinesis. Journal of Clinical Neuroscience,
15(11), 1288-1290. <a
href="http://dx.doi.org/10.1016/j.jocn.2007.09.0
11">[More Information]</a>
Han, S., Boland, R., Krishnan, A., Vucic, S., Lin,
C., Kiernan, M. (2008). Changes in human
sensory axonal excitability induced by an
ischaemic insult. Clinical Neurophysiology,
119(9), 2054-2063. <a
href="http://dx.doi.org/10.1016/j.clinph.2008.04.
295">[More Information]</a>
Vucic, S., Kiernan, M. (2008). Cortical
excitability testing distinguishes Kennedy's
disease from amyotrophic lateral sclerosis.
Clinical Neurophysiology, 119(5), 1088-1096. <a
href="http://dx.doi.org/10.1016/j.clinph.2008.01.
011">[More Information]</a>
Vucic, S., Nicholson, G., Kiernan, M. (2008).
Cortical hyperexcitability may precede the onset
of familial amyotrophic lateral sclerosis. Brain,
131(6), 1540-1550. <a
href="http://dx.doi.org/10.1093/brain/awn071">[
More Information]</a>
Park, S., Krishnan, A., Lin, C., Goldstein, D.,
Friedlander, M., Kiernan, M. (2008).
Mechanisms underlying chemotherapy-induced
neurotoxicity and the potential for
neuroprotective strategies. Current Medicinal
Chemistry, 15(29), 3081-3094. <a
href="http://dx.doi.org/10.2174/0929867087868
48569">[More Information]</a>
Lin, C., Krishnan, A., Lee, M., Zagami, A., You,
H., Yang, C., Bostock, H., Kiernan, M. (2008).
Nerve function and dysfunction in acute
intermittent porphyria. Brain, 131(9), 2510-2519.
<a
href="http://dx.doi.org/10.1093/brain/awn152">[
More Information]</a>
Vucic, S., Kiernan, M. (2008). Normal axonal
ion channel function in large peripheral nerve
fibers following chronic ciguatera sensitization.
Muscle and Nerve, 37(3), 403-405. <a
href="http://dx.doi.org/10.1002/mus.20906">[M
ore Information]</a>
Kiernan, M. (2008). Paraspinal muscles and
amyotrophic lateral sclerosis - getting to the
core? Clinical Neurophysiology, 119(7),
1457-1458. <a
href="http://dx.doi.org/10.1016/j.clinph.2008.03.
013">[More Information]</a>
Stone, R., Archer, J., Kiernan, M. (2008).
Wernicke's encephalopathy mimicking variant
Creutzfeldt-Jakob disease. Journal of Clinical
Neuroscience, 15(11), 1308-1310. <a
href="http://dx.doi.org/10.1016/j.jocn.2007.05.0
22">[More Information]</a>
2007
Vucic, S., Kiernan, M. (2007). Abnormalities in
cortical and peripheral excitability in flail arm
variant amyotrophic lateral sclerosis. Journal of
Neurology, Neurosurgery and Psychiatry, 78(8),
849-852. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17210625">[More Information]</a>
Boland, R., Kiernan, M. (2007). Accuracy Of
Phalen's And Sensory Testing In Diagnosis Of
Carpal Tunnel Syndrome. Proceedings of the
Conference of the International Federation of
Societies for Hand Therapy. IFSHT.
Lin, C., Macefield, V., Wallin, G., Elam, M.,
Engel, S., Kiernan, M. (2007). Axonal changes
in spinal cord injured patients distal to the site of
injury. Brain, 130(Pt 4), 985-994. <a
href="http://dx.doi.org/10.1093/brain/awl339">[
More Information]</a>
Krishnan, A., Hayes, M., Kiernan, M. (2007).
Axonal excitability properties in hemifacial
spasm. Movement Disorders, 22(9), 1293-1298.
<a
href="http://dx.doi.org/10.1002/mds.21512">[M
ore Information]</a>
Vucic, S., Burke, D., Kiernan, M. (2007).
Diagnosis of Motor neuron disease. In Kiernan
M (Eds.), The Motor Neurone Disease
Handbook, (pp. 89-104). Strawberry Hills,
Australia: Australasian Med Publ Co Ltd.
Vucic, S., Burke, D., Kiernan, M. (2007).
Diagnosis of motor neurone disease. In Kiernan
M (Eds.), The Motor Neurone Disease
Handbook, (pp. 89-104). Strawberry Hills,
Australia: Australasian Med Publ Co Ltd.
Vucic, S., Kiernan, M., Krishnan, A. (2007).
Fatigue and activity dependent changes in axonal
excitability in amyotrophic lateral sclerosis.
Journal of Neurology, Neurosurgery and
Psychiatry, 78(11), 1202-1208. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
Publications for Matthew Kiernan
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17371901">[More Information]</a>
Burke, D., Howells, J., Trevillion, L., Kiernan,
M., Bostock, H. (2007). Inflections in threshold
electrotonus to depolarizing currents in sensory
axons. Muscle and Nerve, 36(6), 849-852. <a
href="http://dx.doi.org/10.1002/mus.20862">[M
ore Information]</a>
Boland, R., Han, E., Kiernan, M. (2007).
Ischaemia As A Model Of Focal Nerve Injury.
15th International Congress of the World
Confederation of Physical Therapy WCPT 2007,
United Kingdom: Elsevier.
Herz, H., White, K., Butow, P., Kiernan, M.
(2007). Letter on future care. 10th Congress of
the European Association for Palliative Care.
Boland, R., Lin, C., Krishnan, A., Engel, S.,
Kiernan, M. (2007). Nerve Excitability Changes
In Peripheral Motor Axons In Patients With
Acute Spinal Injury. International Brain
Research Organisation World Congress of
Neuroscience.
Vucic, S., Kiernan, M. (2007). Pathophysiologic
insights into motor axonal function in Kennedy
disease. Neurology, 69(19), 1828-1835. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17984450">[More Information]</a>
Hsing, J., Welgampola, M., Kiernan, M. (2007).
Reversible myeloradiculopathy due to
Mycoplasma pneumoniae. Journal of Clinical
Neuroscience, 14(1), 61-64.
Hsing, J., Welgampola, M., Kiernan, M. (2007).
Reversible myeloradiculopathy due to
Mycoplasma pneumoniae. Journal of Clinical
Neuroscience, 14(1), 61-64. <a
href="http://dx.doi.org/10.1016/j.jocn.2005.08.0
22">[More Information]</a>
Boland, R., Krishnan, A., Kiernan, M. (2007).
Riche-Cannieu anastomosis as an inherited trait.
Clinical Neurophysiology, 118(4), 770-775. <a
href="http://dx.doi.org/10.1016/j.clinph.2006.12.
009">[More Information]</a>
Boland, R., Krishnan, A., Kiernan, M. (2007).
Riche-Cannieu anastomosis as an inherited trait.
Clinical Neurophysiology, 118(4), 770-775. <a
href="http://dx.doi.org/10.1016/j.clinph.2006.12.
009">[More Information]</a>
Boland, R., Kiernan, M. (2007). Riche-Cannieu
Anastomosis In A Family. Proceedings of the
Conference of the International Federation of
Societies for Hand Therapy. IFSHT.
Kiernan, M. (2007). The pain with platinum:
oxaliplatin and neuropathy. European Journal of
Cancer, 43(18), 2631-2633. <a
href="http://dx.doi.org/10.1016/j.ejca.2007.09.00
8">[More Information]</a>
Krishnan, A., Kiernan, M. (2007). Uremic
neuropathy: clinical features and new
pathophysiological insights. Muscle and Nerve,
35(3), 273-290. <a
href="http://dx.doi.org/10.1002/mus.20713">[M
ore Information]</a>
2006
Vucic, S., Howells, J., Trevillion, L., Kiernan,
M. (2006). Assessment of cortical excitability
using threshold tracking techniques. Muscle and
Nerve, 33(4), 477-486. <a
href="http://dx.doi.org/10.1002/mus.20481">[M
ore Information]</a>
Burke, D., Lin, C., Kiernan, M., Bostock, H.
(2006). Assessment of nerve excitability
properties in peripheral nerve disease. In
Kimura J (Eds.), Handbook of Clinical
Neurophysiology, (pp. 381-403). Amsterdam:
Elsevier.
Vucic, S., Kiernan, M. (2006). Axonal
excitability properties in amyotrophic lateral
sclerosis. Clinical Neurophysiology, 117(7),
1458-1466. <a
href="http://dx.doi.org/10.1016/j.clinph.2006.04.
016">[More Information]</a>
Burke, D., Kiernan, M. (2006). Developments in
the assessment of peripheral nerve function. In
Kimura J (Eds.), Handbook of Clinical
Neurophysiology, (pp. 927-943). Amsterdam:
Elsevier.
Boland, R., Kiernan, M. (2006). Evidence for
proximal effects on median nerve function in
carpal tunnel syndrome. Life with Physiotherapy,
Auckland: New Zealand Society of
Physiotherapists.
Krishnan, A., Phoon, R., Pussell, B.,
Charlesworth, J., Bostock, H., Kiernan, M.
(2006). Ischaemia induces paradoxical changes
in axonal excitability in end-stage kidney
disease. Brain, 129(Pt 6), 1585-1592. <a
href="http://dx.doi.org/10.1093/brain/awl099">[
More Information]</a>
Krishnan, A., Phoon, R., Pussell, B.,
Charlesworth, J., Bostock, H., Kiernan, M.
(2006). Neuropathy, axonal Na+/K+ pump
function and activity-dependent excitability
changes in end-stage kidney disease. Clinical
Neurophysiology, 117(5), 992-999. <a
href="http://dx.doi.org/10.1016/j.clinph.2006.02.
002">[More Information]</a>
Winhammar, J., Joffe, D., Simmul, R., Schoeffel,
R., Kiernan, M., Rowe, D. (2006). Nocturnal
hypoxia in motor neuron disease is not predicted
by standard respiratory function tests. Internal
Medicine Journal, 36(7), 419-422. <a
Publications for Matthew Kiernan
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16780447">[More Information]</a>
Vucic, S., Kiernan, M. (2006). Novel threshold
tracking techniques suggest that cortical
hyperexcitability is an early feature of motor
neuron disease. Brain, 129(9), 2436-2446. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16835248">[More Information]</a>
Zoing, M., Burke, D., Pamphlett, R., Kiernan, M.
(2006). Riluzole therapy for motor neurone
disease: an early Australian experience
(1996-2002). Journal of Clinical Neuroscience,
13(1), 78-83. <a
href="http://dx.doi.org/10.1016/j.jocn.2004.04.0
11">[More Information]</a>
Krishnan, A., Phoon, R., Russell, B.,
Charlesworth, J., Kiernan, M. (2006). Sensory
nerve excitability and neuropathy in end stage
kidney disease. Journal of Neurology,
Neurosurgery and Psychiatry, 77(4), 548-551. <a
href="http://dx.doi.org/10.1136/jnnp.2005.07998
8">[More Information]</a>
2005
Boland, R., Kiernan, M. (2005). Accuracy of the
clinical assessment in diagnosis of carpal tunnel
syndrome. Australian Journal of Physiotherapy,
51(4 Supplement), S12-S12.
Boland, R., Kiernan, M. (2005). Accuracy of the
clinical diagnosis in carpal tunnel syndrome.
Clinical Neurophysiology, 116(9), e21-e21.
Kiernan, M., Isbister, G., Lin, C., Burke, D.,
Bostock, H. (2005). Acute tetrodotoxin-induced
neurotoxicity after ingestion of puffer fish.
Annals of Neurology, 57(3), 339-48. <a
href="http://dx.doi.org/10.1002/ana.20395">[Mo
re Information]</a>
Krishnan, A., Phoon, R., Pussell, B.,
Charlesworth, J., Bostock, H., Kiernan, M.
(2005). Altered motor nerve excitability in
end-stage kidney disease. Brain, 128(Pt 9),
2164-2174. <a
href="http://dx.doi.org/10.1093/brain/awh558">[
More Information]</a>
Winhammar, J., Rowe, D., Henderson, R.,
Kiernan, M. (2005). Assessment of disease
progression in motor neuron disease. The Lancet
Neurology, 4(4), 229-238. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15778102">[More Information]</a>
Boland, R., Krishnan, A., Kiernan, M. (2005).
Median nerve excitability during upper limb
ischaemia in patients with carpal tunnel
syndrome. Australian Journal of Physiotherapy,
51(4 Supplement), S12-S12.
Kiernan, M., Krishnan, A., Lin, C., Burke, D.,
Berkovic, S. (2005). Mutation in the Na+
channel subunit SCN1B produces paradoxical
changes in peripheral nerve excitability. Brain,
128(8), 1841-1846. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15857929">[More Information]</a>
Burke, D., Kiernan, M., Bostock, H. (2005).
Nerve Excitability Measures: Biophysical Basis
and Use in the Investigation of Peripheral Nerve
Disease. In Peter J. Dyck, P.K. Thomas (Eds.),
Peripheral Neuropathy, Volume 1, (pp.
113-129). Philadelphia, Pennsylvania: Saunders
Elsevier.
2004
Krishnan, A., Pamphlett, R., Burke, D., Wills, E.,
Kiernan, M. (2004). Cytoplasmic Body
Myopathy Masquerading As Motor Neuron
Disease. Muscle and Nerve, 30(5), 667-672. <a
href="http://dx.doi.org/10.1002/mus.20115">[M
ore Information]</a>
Kiernan, M., Lin, C., Burke, D. (2004).
Differences In Activity-Dependent
Hyperpolarization In Human Sensory And Motor
Axons. The Journal of Physiology, 558(1),
341-349.
2001
Burke, D., Kiernan, M., Bostock, H. (2001).
Excitability of human axons. Clinical
Neurophysiology, 112(9), 1575-1585.
Cumming, S., Harris, L., Kiernan, M., Williams,
R. (2001). Semantic Priming of Expectancies
Among High-and Low-restraint Non-problem
Drinkers. Australian Journal of Psychology, 53
No 3, 155-159.